Xiao-Li Xu (Xiaoli Xu)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Venues

Journal of medicinal chemistry

Science advances

Future medicinal chemistry

Current drug targets

China Pharmaceutical University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

China Pharmaceutical University

China

associate professor :: Medicinal chemistry department

Publications

Shi-Duo Zhang, Hui Li, Ye-Ling Zhou, Xue-Chun Liu, De-Chang Li, Chuan-Feng Hao, Qi-Dong You, Xiao-Li Xu
Protein-protein interactions in cGAS-STING pathway: a medicinal chemistry perspective. Future medicinal chemistry (2024)
Hui Li, Sheng-Lie Zhang, Yan-Han Jia, Qian Li, Zi-Wen Feng, Shi-Duo Zhang, Wei Zheng, Ye-Ling Zhou, Lin-Lin Li, Xue-Chun Liu, Ya-Qiong Chen, Hui Peng, Qi-Dong You, Xiao-Li Xu
Imidazo[1,2- a ]Pyridine Derivatives as Novel Dual-Target Inhibitors of ABCB1 and ABCG2 for Reversing Multidrug Resistance. Journal of medicinal chemistry 66 (4) (2023)
Nan-Nan Chen, Han Zhang, Qiang-Sheng Zhu, Ting Zeng, Wei Dai, Ye-Ling Zhou, Guo-Feng Xin, Bei-Duo Wu, Si-Jia Gong, Zheng-Yu Jiang, Qi-Dong You, Xiao-Li Xu
Development of Orally Bioavailable Amidobenzimidazole Analogues Targeting Stimulator of Interferon Gene (STING) Receptor. Journal of medicinal chemistry (2023)
Hui Li, Sheng-Lie Zhang, Yan-Han Jia, Qian Li, Zi-Wen Feng, Shi-Duo Zhang, Wei Zheng, Ye-Ling Zhou, Lin-Lin Li, Xue-Chun Liu, Ya-Qiong Chen, Hui Peng, Qi-Dong You, Xiao-Li Xu
Imidazo[1,2- a ]Pyridine Derivatives as Novel Dual-Target Inhibitors of ABCB1 and ABCG2 for Reversing Multidrug Resistance. Journal of medicinal chemistry 66 (4) (2023)
Hui Li, Sheng-Lie Zhang, Yan-Han Jia, Qian Li, Zi-Wen Feng, Shi-Duo Zhang, Wei Zheng, Ye-Ling Zhou, Lin-Lin Li, Xue-Chun Liu, Ya-Qiong Chen, Hui Peng, Qi-Dong You, Xiao-Li Xu
Imidazo[1,2- a ]Pyridine Derivatives as Novel Dual-Target Inhibitors of ABCB1 and ABCG2 for Reversing Multidrug Resistance. Journal of medicinal chemistry 66 (4) (2023)
Feng Xu, Xinjian Tian, Qiangsheng Zhu, Ziwen Feng, Hui Li, Wei Dai, Yeling Zhou, Qi-Dong You, Xiao-Li Xu
Inhibitors of stimulator of interferon genes from 2019 to July 2022: An overview of the structure and bioactivity. Current drug targets (2023)
Hui Li, Sheng-Lie Zhang, Yan-Han Jia, Qian Li, Zi-Wen Feng, Shi-Duo Zhang, Wei Zheng, Ye-Ling Zhou, Lin-Lin Li, Xue-Chun Liu, Ya-Qiong Chen, Hui Peng, Qi-Dong You, Xiao-Li Xu
Imidazo[1,2- a ]Pyridine Derivatives as Novel Dual-Target Inhibitors of ABCB1 and ABCG2 for Reversing Multidrug Resistance. Journal of medicinal chemistry (2023)
Hui Li, Sheng-Lie Zhang, Yan-Han Jia, Qian Li, Zi-Wen Feng, Shi-Duo Zhang, Wei Zheng, Ye-Ling Zhou, Lin-Lin Li, Xue-Chun Liu, Ya-Qiong Chen, Hui Peng, Qi-Dong You, Xiao-Li Xu
Imidazo[1,2- a ]Pyridine Derivatives as Novel Dual-Target Inhibitors of ABCB1 and ABCG2 for Reversing Multidrug Resistance. Journal of medicinal chemistry 66 (4) (2023)
Qiangsheng Zhu, Nannan Chen, Xinjian Tian, Yeling Zhou, Qi-Dong You, Xiao-Li Xu
Hematopoietic Progenitor Kinase 1 in Tumor Immunology: A Medicinal Chemistry Perspective. Journal of medicinal chemistry 65 (12) (2022)
Lei Wang, Jingsheng Jiang, Lixiao Zhang, Qiuyue Zhang, Jianrui Zhou, Li Li, Xiao-Li Xu, Qi-Dong You
Discovery and Optimization of Small Molecules Targeting the Protein-Protein Interaction of Heat Shock Protein 90 (Hsp90) and Cell Division Cycle 37 as Orally Active Inhibitors for the Treatment of Colorectal Cancer. Journal of medicinal chemistry 63 (3) (2020)
Lei Wang, Lixiao Zhang, Li Li, Jingsheng Jiang, Zhen Zheng, Jialin Shang, Chengxiang Wang, Weilin Chen, Qichao Bao, Xiao-Li Xu, Zheng-Yu Jiang, Jian Zhang, Qi-Dong You
Small-molecule inhibitor targeting the Hsp90-Cdc37 protein-protein interaction in colorectal cancer. Science advances 5 (9) (2019)
Han Zhang, Qi-Dong You, Xiao-Li Xu
Targeting Stimulator of Interferon Genes (STING): A Medicinal Chemistry Perspective. Journal of medicinal chemistry 63 (8) (2019)
Li Li, Lei Wang, Qi-Dong You, Xiao-Li Xu
Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions. Journal of medicinal chemistry 63 (5) (2019)

Xiao-Li Xu.css-eqlu8i{font-size:small;padding-left:4px;} (Xiaoli Xu)

Publication Activity (10 Years)

Top Topics

Top Venues

Xiao-Li Xu (Xiaoli Xu)